Skip to main content
PLOS One logoLink to PLOS One
. 2020 Apr 2;15(4):e0230976. doi: 10.1371/journal.pone.0230976

Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait

Ghayda Al-Hashem 1, Vincent O Rotimi 1, M John Albert 1,*
Editor: Martina Crivellari2
PMCID: PMC7127897  PMID: 32240218

Abstract

Acinetobacter baumannii is an opportunistic pathogen of intensive care unit (ICU) patients. A. baumannii colonizes many parts of the body including the gastrointestinal tract. Endemic and epidemic strains are polyclonal. There is no clarity on the origin of polyclonality of A. baumannii. The objective of the study was to define the genetic relatedness of serial isolates and the origin of polyclonality. Serial rectal isolates from ICU patients whose rectum was colonized on ≥5 sampling occasions were selected. From a total of 32 eligible colonized patients, isolates from a subgroup of 13 patients (a total of 108 isolates) showing different patterns of colonization as revealed by pulsed-field gel electrophoresis (PFGE) were studied. The isolates were analyzed by PFGE pulsotypes, sequence types (STs) by multi-locus sequence typing (MLST) and clonal complex (CC) by eBURST analysis. Serial isolates constituted a mixture of identical, related and unrelated pulsotypes. Analysis by STs and CCs were less discriminatory. The data suggest a combination of an initial colonizing isolate undergoing mutation as well as colonization by independent isolates. Further clarity on the origin of diversity should be better obtained by whole-genome sequencing.

Introduction

Acinetobacter baumannii causes severe nosocomial infections in critically ill patients and is involved in many hospital outbreaks world-wide. It colonizes skin and mucous membranes including the gastrointestinal tract [1,2]. This organism has the propensity for acquiring multiple resistance genes with phenotypic expression of multidrug-resistant (MDR) characteristics. MDR strains are now endemic in many hospitals around the world, including hospitals in Kuwait [3,4]. Choosing appropriate molecular typing methods is vital for investigating epidemiological lineages of the isolates and for infection control. Numerous molecular typing methods are available including pulsed-field gel electrophoresis (PFGE) [5], random amplified polymorphic DNA (RAPD) analysis [6], ribotyping [7], multilocus PCR and electrospray ionization mass spectrometry (PCR/ESI-MS) [8], amplified fragment length polymorphism (AFLP) analysis [7], repetitive extragenic palindromic sequence-based PCR (rep-PCR) [9], and infrequent-restriction-site analysis [10]. PFGE is used as a common method for typing A. baumannii isolates [11]. Even though PFGE has a high discriminatory power, it cannot be used for comparison of data among laboratories because of technical variations [12, 13]. A. baumannii has a unique blaOXA-51-like gene that may be used for species identification and PCR-based typing into sequence groups (SGs) [14]. Multilocus sequence typing (MLST), has been used successfully for global comparison of isolates [15,16]. eBURST is used to compare the relatedness of isolates by a single locus difference as PFGE compares the isolates by the size of the restricted segments of DNA. In eBURST analysis, the relationship of isolates is presented graphically [17]. Whole-genome sequencing (WGS) has been used recently for epidemiological investigations [18]. Even though, it is more discriminatory than other methods, the technology is complex and expensive and not amenable to many laboratories [19].

In the adult intensive care unit (ICU) of the Mubarak Al Kabeer Hospital, which is a tertiary teaching hospital in Kuwait, there have been several outbreaks of MDR A. baumannii infection [4,20]. The outbreak isolates were found to be multiple clones that were on many occasions not similar or related when typed by PFGE. Also, patient and hospital environmental isolates were not related. Endemic strains from ICUs without outbreaks also exhibited polyclonality [4]. Hence, we hypothesized that the patient gut environment may contribute to the origin of genetic diversity of these isolates, where the isolates may undergo acquisition or loss of specific mobile gene elements or recombination events under the selection pressure of antibiotic exposure during the prolonged hospital stay of patients. A. baumannii has a highly plastic genome with the resultant gain or loss of genetic materials [21]. Therefore, we studied the genetic relatedness of serial A. baumannii isolates colonizing the rectum of adult ICU patients at Mubarak Al Kabeer Hospital. We typed the isolates by the commonly available PFGE, MLST and eBURST methods to determine whether these methods will give sufficient insights into the evolution of colonizing strains.

Methodology

Patients and study design

This study was carried out in the adult ICU of Mubarak Al Kabeer Hospital, Kuwait. The hospital has a total of 850 beds including 30 beds in the adult ICU. The catchment area for this hospital covers a population of approximately 800,000 people. The period of study was from March 2015 to June 2016. Rectal swabs were collected from newly admitted patients on the day of admission, third day after admission and then twice weekly until the patient was either discharged or dead. Patients who had five or more positive cultures on different days were included in the final analysis. Relevant information such as age, gender, nationality, diagnosis and comorbidity, antibiotic therapy, previous hospital admission, and live discharge or death, were carefully recorded.

Isolation and identification

The rectal swabs were inoculated into an enrichment broth containing acetate and incubated aerobically at 37°C for 48 h [22]. The enriched culture was subcultured onto Acinetobacter CHROMagar (CHROMagar, Paris, France) and incubated at 37°C for 48 h. Different morphotypes of typical large red colonies were selected for further identification by API NE20 (bioMérieux, I’Etoile, Marcy, France) and confirmed by a duplex PCR assay for gyrB gene according to Higgins et al 2007 [23].

Antibiotic susceptibility testing

Antibiotic susceptibility testing of the isolates was performed by E-test method (bioMerieux) and interpreted according to Clinical and Laboratory Standards Institute (CLSI) susceptibility criteria [24]. Susceptibility to tigecycline was determined according to the criteria of Talaga et al [25]. Susceptibility to colistin was performed by agar dilution method and interpreted by the CLSI criteria [24].

Typing by DiversiLab

To determine how many colonies from a patient culture plate should be analyzed, we hypothesized that there are different colony morphotypes of A. baumannii on CHROMagar and each colony morphotype represented a different genetic type. To test this hypothesis, in a preliminary pilot study, we tested colonies from 12 patients. The isolates were typed by repetitive sequence-based PCR (DiversiLabTM System; bioMérieux). Clonal relatedness was analyzed with the DiversiLab software using the Pearson correlation statistical method. Relatedness was defined as: ≥98% similarity as identical, ≥ 95% and <98% similarities as related, and <95% similarity as unrelated.

Typing by pulsed field-gel electrophoresis (PFGE)

PFGE was performed as previously described by Seifert et al 2005 with ApaI restriction enzyme. [26]. The apparatus and conditions as [27]. Strain relatedness was analyzed by BioNumerics software (Applied Maths, bioMérieux). The percentage of similarity was calculated by dice coefficient with 1.5% tolerance and 1.5% optimization with a cutoff point of 100% for identical, ≥80% related and <80% unrelated isolates [28,29]. Major pulsotypes were represented by different clades. Isolates within the same clades were denoted as subtypes if they exhibited ≥80% and < 100% relatedness. Strain relatedness as identical, related and unrelated was also determined manually by the criteria of Tenover et al [29].

Patients were given alphabetical identification and the serial isolates from a patient were denoted by the patient alphabet and a number representing the sampling number. For example, serial isolates of patient A were denoted as A1, A2, A3, etc. The relatedness of subsequent isolates to the first isolate was indicated as identical (I), related (R), or unrelated (U). If more than one colony morphotypes were studied, the morphotypes were denoted by lower case alphabets. For example, A5a and A5b, meant that on the 5th sampling of patient A, there were two colony morphotypes, a and b.

Grouping of patients based on PFGE

Based on PFGE typing of serial isolates, patients were grouped based on appearance and disappearance of various PFGE types (Table 1). This analysis segregated patients into 4 groups. Serial isolates from one or more patients representing each group was further studied as outlined below.

Table 1. Grouping pattern of 270 isolates from 32 patients by PFGE.

Group Relatedness of isolates Patient (number of isolates)
1 Colonization with identical and related isolates E(7), Q(5), Y(6)
2 Colonization with identical, related and unrelated isolates A(6), C(8), F(5), K(6), L(12), M(10), N(13), P(8), R(8), S(8), U(5), W(9), Z(12), AA(10), AB(12), AD(8), AF(6),
3 Colonization with related and unrelated isolates B(7), D(7), G(9), H(6), O(6), T(7), V(5)
4 Colonization by unrelated isolates I(12), J(16), X(11), AC(8), AE(12)

Multi-locus sequence typing (MLST)

MLST was performed as described previously by Bartual et al, 2005 [30] for the Oxford theme. The final purified product was sequenced in a sequencing machine (3130xl Genetic analyzer, Applied BioSystems, CA, United States). Sequences were trimmed to the required lengths and compared by Clustal X and the sequence type determined on the website https://pubmlst.org/abaumannii/ [31].

Whole genome sequencing (WGS)

Sequencing libraries were prepared using the Nextera XT DNA sample preparation kit (Illumina, San Diego, CA, USA) and the sequence read data were produced on the Illumina NextSeq instrument (paired end, 150 base reads). De novo assembly of the read data of the isolate was performed using MegaHit [32]. The resulting draft genome sequence was used to derive MLST (PubMLST: https://pubmlst.org/ for Oxford scheme).

Only the isolate K5 was subjected to WGS because the sequence of gpi gene for MLST could not be determined due to lack of priming of the forward primer (See under RESULTS, S3 Fig and S3 Table).

eBURST analysis

eBURST was used to analyze the MLST data to determine the evolutionary relationships among the isolates. The eBURST diagram was constructed by version 3.0 software (http://eburst.mlst.net/), using all available data from the A. baumannii PubMLST database. A complete MLST database was visualized as a single eBURST diagram.

Ethics statement

The ethical approval for this study was granted by the Ethics Committee, Ministry of Health, State of Kuwait (approval number 112). All patients voluntarily gave written informed consent for rectal swab collection and data collection.

Results

Comparison of colony morphotypes with DiversiLab types

The results of the analysis on 12 patients are shown in S1 Table and sample DiversiLab dendrograms in S1 Fig. Studies of three different colonies from five patients (nos. 1, 5, 7, 9, 10) showing a single morphotype revealed that all three colonies were identical by DiversiLab. On the other hand, when colonies of different morphotypes were studied from the remaining seven patients, the colonies were either related or unrelated, but not identical. Based on this observation, single colonies representing each morphotype were studied from the patients from whom serial rectal samples were analyzed.

Study of patients with serial rectal swab collection

A total of 493 patients were studied over a period of 16 months (from March 2015 to June 2016) from whom 1912 rectal swab specimens were collected. Of these, 117 (23.7%) patients and 475 (24.8%) swabs were positive with red colonies resembling Acinetobacter spp. on Acinetobacter CHROMAgar. The isolates were then confirmed as A. baumannii by blagyrB PCR assays. Seventy-three (62.4%) patients were colonized after 72 h of admission, and 44 patients (37.6%) were colonized on the day of admission. The latter were regarded as colonization before admission to the ICU and therefore omitted from the analysis because we did not know the colonization history of already colonized patients. Of the 73 patients who acquired the isolates in the ICU, 32 (43.8%) were colonized on multiple occasions (≥5 times) yielding a total of 270 isolates.

Antibiogram of isolates

The antibiotic resistance data are shown in S2 Table. Most of the isolates, 89 (82.4%), were multidrug-resistant (MDR) (resistant to ≥3 antibiotic classes). There was no consistent pattern of resistance in serial isolates from patients.

Pulse field gel electrophoresis typing

PFGE typing of 270 isolates from 32 patients resulted in the patients being assigned into four groups as shown in Table 1. This grouping is based on the relationship of subsequent isolates to first isolates as I, R or U. Isolates (n = 108) from thirteen patients representing all the four groups (patients Y, N, R, I, J, S, V, G, O, A, AF, K and B) were further studied. The dendrograms of the isolates from these thirteen patients are given in Fig 1 and the relationship of serial isolates are shown in Table 2. There was better differentiation of I and R isolates by BioNumerics method than by Tenover method. Both methods differentiated U isolates similarly.

Fig 1. PFGE dendrograms of thirteen patients (Y, N, R, I, J, S, V, G, O, A, AF, K, B) belonging to six groups determined by PFGE grouping.

Fig 1

Table 2. Typing of serial isolates of A. baumannii colonizing the rectum of patients by PFGE, MLST and eBURST.

Group Patient Isolate no. Date of isolation PFGE relatedness PFGE pulsotypeby BioNumerics method PFGE relatedness by Tenover pulsotype ST no. eBurst (Clonal complex)
by BioNumerics method
1 Y Y1 19-Feb-2016 FI 1a FI 195 CC 208
Y2 23-Feb-2016 R 1b R 452 CC 208
Y3 2-Mar-2016 I 1a I 195 CC 208
Y4 5-Mar-2016 I 1a I 195 CC 208
Y5a 9-Mar-2016 R 1c I 195 CC 208
Y5b 9-Mar-2016 R 1c I 195 CC 208
2 A A1 21-Apr-2016 FI 1a FI 884 CC 884
A2 28-Apr-2016 I 1a I 884 CC 884
A3 19-May-2016 R 1b R 218 CC 208
A4 22-May-2016 R 1c I 218 CC 208
A5a 28-May-2016 R 1b R 884 CC 884
A5b 28-May-2016 U 2 U 218 CC 208
2 K K1 19-May-2015 FI 1a FI 218 CC 208
K2 8-Jun-2015 R 1b I 218 CC 208
K3 30-Jun-2015 I 1a I 218 CC 208
K4 24-Jul-2015 R 1c I 218 CC 208
K5 18-Sep-2015 U 2 U NEW1 NEW1
K6 25-Nov-2015 U 3 U 368 CC 208
2 N N1 3-Nov-2015 FI  Ia FI 195 CC 208
N2 6-Nov-2015  R  1b U 195 CC 208
N3 18-Dec-2015  I  1a I 195 CC 208
N4a 12-Feb-2016  R  1c R 195 CC 208
N4b 12-Feb-2016  R  1d R 195 CC 208
N5a 19-Feb-2016  R  1e R 195 CC 208
N5b 19-Feb-2016  R  1f R 195 CC 208
N6a 23-Feb-2016  U  2a U 195 CC 208
N6b 23-Feb-2016  U  2b U 195 CC 208
N7a 2-Mar-2016  U  3a U 195 CC 208
N7b 2-Mar-2016  U  3b U 195 CC 208
N8 2-Apr-2016  U  3c U 218 CC 208
N9 20-Apr-2016  U  4 U 218 CC 208
2 R R1 17-Jan-2016 FI 1a FI 218 CC 208
R2 2-Feb-2016 U 2a U 884 CC 884
R3a 9-Feb-2016 R 1b R 884 CC 884
R3b 9-Feb-2016 U 3 U NEW2 NEW2
R4 19-Feb-2016 U 3 U NEW2 NEW2
R5a 9-Mar-2016 U 4 U 884 CC 884
R5b 9-Mar-2016 U 4 U 884 CC 884
R6 12-Mar-2016 U 2b U 884 CC 884
2 S S1 6-Nov-2015 FI 1a FI 218 CC 208
S2 16-Feb-2016 R 1b R 195 CC 208
S3a 12-Mar-2016 R 1d R 195 CC 208
S3b 12-Mar-2016 U 2 U 195 CC 208
S4a 23-Mar-2016 R 1c R 195 CC 208
S4b 23-Mar-2016 R 1d R 195 CC 208
S5 13-Apr-2016 U 3 U 195 CC 208
S6 4-May-2016 U 1d R 195 CC 208
2 AF AF1 9-Apr-2016 FI 1a FI 218 CC 208
AF2 16-Apr-2016 R 1b I 218 CC 208
AF3 27-Apr-2016 R 1c I 218 CC 208
AF4 7-May-2016 I 1a I 218 CC 208
AF5 11-May-2016 R 1d I 218 CC 208
AF6 26-May-2016 U 2 I 218 CC 208
3 B B1 31-Mar-2015 FI 1a FI 218 CC 208
B2 3-Apr-2015 U 2 U 218 CC 208
B3 11-Apr-2015 R 1b U 218 CC 208
B4 21-Apr-2015 U 3 U 218 CC 208
B5 24-Apr-2015 R 1c U 218 CC 208
B6 28-Apr-2015 U 4 U 1208 CC 355
B7 9-May-2015 U 5 U 218 CC 208
3 G G1a 28-Apr-2016 FI 1a FI 218 CC 208
G1b 28-Apr-2016 U 2 U 218 CC 208
G2 1-May-2016 R 1b R 218 CC 208
G3a 2-Jun-2016 R 1c R 218 CC 208
G3b 2-Jun-2016 U 3 U 218 CC 208
G4 8-Jun-2016 U 4 U 218 CC 208
G5a 16-Jun-2016 R 1d R 218 CC 208
G5b 16-Jun-2016 R 1e R 218 CC 208
G5c 16-Jun-2016 R 1f R 218 CC 208
3 O O1 21-Aug-2015 FI 1a FI 1980 CC 1980
O2 1-Sep-2015 R 1b R 1980 CC 1980
O3 19-Oct-2015 R 1c U NEW3 NEW3
O4 27-Oct-2015 U 2a U 1980 CC 1980
O5 30-Oct-2015 U 2b U 1980 CC 1980
O6 6-Nov-2015 U 3 U 218 CC 208
3 V V1 8-Jan-2016 FI 1a FI 218 CC 208
V2 12-Jan-2016 R 1b U 1418 CC 234
V3 22-Jan-2016 U 2 U 1418 CC 234
V4 26-Jan-2016 U 3 U 1418 CC 234
V5 2-Feb-2016 R 1c I 1418 CC 234
4 I I1 12-May-2015 FI 1 FI NEW4 NEW4
I2a 22-May-2015 U 2 U 368 CC 208
I2b 22-May-2015 U 3 U 368 CC 208
I3a 5-Jun-2015 U 4 U 368 CC 208
I3b 5-Jun-2015 U 5a U 368 CC 208
I4 4-Sep-2015 U 5b U 218 CC 208
I5 13-Oct-2015 U 5c U 218 CC 208
I6 17-Nov-2015 U 6a U 884 CC 884
I7a 19-Feb-2016 U 7 U 884 CC 884
I7b 19-Feb-2016 U 6b U 884 CC 884
I8 9-Mar-2016 U 5d U 195 CC208
I9 20-Apr-2016 U 6c U 884 CC884
4 J J1 22-May-2015 FI 1 FI 218 CC 208
J2 2-Jun-2015 U 2a U 218 CC 208
J3a 26-Jun-2015 U 3a U 218 CC 208
J3b 26-Jun-2015 U 3b U 218 CC 208
J4a 3-Jul-2015 U 4a U 218 CC 208
J4b 3-Jul-2015 U 4b U 218 CC 208
J5 17-Jul-2015 U 3c U NEW5 NEW5
J6 19-Sep-2015 U 3d U NEW5 NEW5
J7 30-Oct-2015 U 4c U NEW5 NEW5
J8 13-Nov-2015 U 5 U NEW5 NEW5
J9 18-Dec-2015 U 6 U NEW6 NEW6
J10a 16-Feb-2016 U 2b U NEW6 NEW6
J10b 16-Feb-2016 U 2c U NEW6 NEW6
J11 30-Mar-2016 U 3c U NEW6 NEW6
J12a 2-Apr-2016 U 7a U NEW6 NEW6
J12b 2-Apr-2016 U 7b U NEW6 NEW6

FI is first isolate; the relationship of first isolate to subsequent isolates are I identical, R related or U unrelated; ST no: Sequence type number; CC clonal complex., NEW is new sequence type

Multi-locus sequence typing

The analysis of serial isolates by MLST showed different patterns. There was a single ST in patients G and AF; two STs in patients B, A, V, S, N and Y; a single ST and two novel STs in patient J; two STs and a novel ST in patients O, R and K; and four STs and a novel ST in patient I. The rank order of prevalence of STs were: 42 isolates of ST218, 24 isolates of ST195, 12 isolates of ST884, 6 isolates of novel ST NEW4, 5 isolates of ST368, 4 isolates each of ST1418, ST1980 and novel ST NEW3, 2 isolates of novel ST NEW1, and one isolate each of ST452, ST1208, and novel STs, NEW2, NEW5 and NEW6.

Novel STs, NEW1 to NEW4 had new allele combinations not described in the Oxford scheme. These are shown in S3 Table. Novel ST, NEW3 in patient O had the following alleles: gltA(1), gyrB (17), gdhB(139), recA(12), cpn60 (had a new sequence [S2 Fig]), gpi(170), rpoD(5). Novel ST, NEW1 in patient K had the following alleles: gltA(21), gyrB(15), gdhB(139), recA(12), cpn60(23), gpi (could not be sequenced by Sanger sequencing due to lack of binding of forward primer, but sequence obtained by Illumina sequencing, see S3 Fig), rpoD (4). All these new MLSTs were uploaded onto the Oxford MLST server.

Clonal complex determination

eBURST analysis of 108 isolates from the thirteen patients is shown Table 2 and in Figs 2 and 3. The clonal complex (CCs) were CC208, CC234, CC355, and CC884. The singleton isolates were CC1980, and NEW1 to NEW6.

Fig 2. eBURST diagram generated with MLST data representing the phylogenic relatedness of the seven A. baumannii ST types (195, 452, 218,368, 884,1208 and 1418).

Fig 2

ST208, ST884, ST355 and ST234 are the clonal complex origins of CC208, CC234, CC884 and CC355, and the STs close to them differed by a single locus sequence type. Isolates further away have a double or more locus sequence type differences. Seven STs (1980 and 6 novel sequence types) from our study are not shown because they are singletons.

Fig 3. eBURST diagram generated with MLST data representing phylogenic relatedness of the five major clonal complexes (CC208, CC234, CC884, CC355, CC1980) of A. baumannii.

Fig 3

Comparison of isolates by PFGE, ST and CC

Comparison of differentiation of the isolates by the three typing methods is shown in Table 2.

In general, there were more pulsotypes and subtypes by PFGE compared to less number of STs and CCs in all patients. As examples, patient J was colonized by 7 major BioNumerics pulsotypes with 4 pulsotypes showing 3, 4, 3 and 2 subtypes respectively. These isolates belonged to 3 STs and 3 CCs. Patient S was colonized by 3 major BioNumerics pulsotypes with 1 pulsotype showing 4 subtypes. These pulsotypes were represented by 2 STs and 1 CC. These types of better differentiation by pulsotypes can be seen in other patients.

Discussion

DiversiLab typing was used to ascertain the genetic relationship of colony morphotypes. Our study on 12 patients showed that colonies exhibiting similar morphologies were identical genetically, and colonies of different morphologies differed genetically. Based on these observations, the number of colonies picked for the study of the 32 patients who had serial rectal samples studied, depended on the number of colony morphotypes, that is, one colony representing each morphotype was studied. We chose DiversiLab typing for the study of colony morphotypes because it is an automated method and easier than PFGE. Previous studies have demonstrated that there is a high degree of correlation between DiversiLab typing and PFGE [33].

By simply defining the relationship of the first isolate to the subsequent isolates as I, R or U in PFGE typing, we could assign 32 patients into 4 different groups (Table 1). One or five patients from each group were chosen for the current study. Further analysis of PFGE results into pulsotypes, showed the following grouping of patients: colonization with identical and related isolates (patient Y), colonization with identical, related and unrelated isolates (patients N, R, S, A, AF and K), and colonization with related and unrelated isolates (patients G, J, V, O, B and I). It is tempting to conclude that related isolates may have evolved from an initial isolate that has undergone independent mutation by itself or by genetic exchange with other strains. This is a possibility as A. baumannii has a highly plastic genome and is promiscuous in exchange of genetic materials [34]. It is conceivable that unrelated isolates represent independent isolates. Also, the automated BioNumerics pulsotyping has better discrimination than the manual Tenover pulsotyping.

There was less variability among isolates when typed by MLST or eBURST. There were eight STs that were detected in our study, ST218, ST195, ST1208, ST1980, ST452, ST368, ST1418 and ST884. For NEW1 isolate, no amplified product for gpi was obtained. This is due to lack of priming of the forward primer (S3 Fig). Others have previously noted a similar problem with Oxford MLST scheme [35,36]. By CC analysis, most of the isolates belonged to one type, CC208. In addition, there were singletons: ST1980 and those representing the six new STs. Our findings are supported by previous studies that have shown that PFGE typing is more discriminatory than MLST typing or eBURST analysis [37].

It is worth comparing the STs in our study with those from other studies in the region. In an Iranian study [38], the STs were 195, 387, 451, 460 and 848. In a study from Saudi Arabia, eight different STs– 195, 208, 218, 222, 231, 286, 499 and 557- were obtained. In a multicenter study covering the Gulf Cooperation Council (GCC) countries- Saudi Arabia, United Arab Emirates, Sultanate of Oman, Qatar, Bahrain, and Kuwait [39]—seven different STs (195, 208, 229, 436, 450, 452 and 499) and three novel STs were seen. One or two out of eight STs obtained in our study– 195, 218- were present in studies in Iran, Saudi Arabia or GCC countries. Our experience suggests that PFGE typing is a better discriminatory method which is suited for investigation of outbreaks in a hospital, but for inter-country comparison of isolates, STs are suitable even though MLST is less discriminatory.

There are some limitations in our study. First, with regard to isolation of A. baumannii, we enriched the rectal swabs in a liquid medium and then subcultured onto a selective agar. It is possible that this procedure might have selected out some strains, but not others. Therefore, the isolation method may not reveal the true picture of colonizing strains. Second, we did not compare the colonizing strains among patients to find out transmission of certain strains between patients. We did not deliberately do this type of comparison as the primary purpose of our study was to characterize the serial isolates colonizing individual patients. Our study was not intended to gauge transmission between patients from the standpoint of infection control.

Conclusions

Our data suggested that serial colonization of rectum may be due to an initial isolate that has undergone mutation or colonization by independent isolates or a combination of both. Further insight into the origin of isolates colonizing this group of patients in long-stay high dependency units could be obtained by whole-genome sequencing and bioinformatics analysis.

Supporting information

S1 Table. The relationship of colonies by DiversiLab dendrograms among similar and different morphotypes.

(DOCX)

S2 Table. Antimicrobial susceptibilities of 108 serial rectal A. baumannii isolates from 13 patients.

(DOCX)

S3 Table. Combination of gene alleles for novel MLSTs.

(DOCX)

S1 Fig. The relationship of colonies of similar and different colony morphotypes by DiversiLab dendrogram.

Patients 1, 5 and 7 each had similar colony morphotypes. Three colonies each from these patients were genetically identical by DiversiLab. Patients 3, 6 and 8 had 3, 4 and 6 colony morphotypes, respectively. DiversiLab analysis of these colonies showed different genetic types.

(TIF)

S2 Fig. Novel cpn60 allele and genome sequence based MLST type for the Oxford scheme from isolate O3 (designated as NEW3) (fasta file).

(TIF)

S3 Fig. gpi sequence of A. baumannii isolate K5 (designated as NEW4) showing lack of binding of forward primer.

(TIF)

Acknowledgments

The authors are grateful to Dieter Bulach, Peter Doherty Institute for Infection and Immunity, the University of Melbourne, Australia, for help with bioinformatics of whole genome sequence.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The study was funded by a Kuwait University Research grant (YM03/15) to MJA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, et al. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multi-resistant Acinetobacter baumannii in ICU patients. J Hosp Infect. 1997; 37:287–295. 10.1016/s0195-6701(97)90145-6 [DOI] [PubMed] [Google Scholar]
  • 2.Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis. 2010; 14: e764–769. 10.1016/j.ijid.2010.02.2254 [DOI] [PubMed] [Google Scholar]
  • 3.Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne J-P. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int. 2014:305784 10.1155/2014/305784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jamal W, Salama M, Shahin M, Rotimi V. The burden of Acinetobacter baumannii in the intensive care unit of a teaching hospital in Kuwait over a 3-year period. Open Forum Infect Dis. 2017; 4: S174–175. 10.1093/ofid/ofx163.317 [DOI] [Google Scholar]
  • 5.Durmaz R, Otlu B, Koksal F, Hosoglu S, Dis RO-JJI. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn.J. Infect. Dis.2009; 47:2452–2457. 10.1128/JCM.00476-09.6 [DOI] [PubMed] [Google Scholar]
  • 6.Chatterjee S, Datta S, Roy S, Ramanan L, Saha A, Viswanathan R, et al. Carbapenem resistance in Acinetobacter baumannii and other Acinetobacter spp. causing neonatal sepsis: focus on NDM-1 and its linkage to ISAba125. Front Microbiol. 2016; 8:1126 10.3389/fmicb.2016.01126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rafei R, Kempf M, Eveillard M, Dabboussi F, Hamze M, Joly-Guillou M-L. Current molecular methods in epidemiological typing of Acinetobacter baumannii. Future Microbiol. 2014; 9:1179–1194. 10.2217/fmb.14.63 [DOI] [PubMed] [Google Scholar]
  • 8.Sarovich DS, Colman RE, Price EP, Massire C, Von Schulze AT, Waddell V, et al. Molecular genotyping of Acinetobacter spp. isolated in Arizona, USA, using multilocus PCR and mass spectrometry. J Med Microbiol. 2013; 62:1295–1300. 10.1099/jmm.0.052381-0 [DOI] [PubMed] [Google Scholar]
  • 9.Kian B, Mirnejad R, Moradli G, Mirkalantari S, Golmohammadi R. Molecular genotyping of Acinetobacter baumannii species isolated from patients in Tehran, Iran, by repetitive element PCR fingerprinting. Iran J Pathol. 2018; 13:144–150. 10.30699/ijp.13.2.144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rafei R, Dabboussi F, Hamze M, Eveillard M, Lemarié C, Gaultier M-P, et al. Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods. PLoS One. 2014; 9: e115969 10.1371/journal.pone.0115969 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vanegas Múnera JM, Jiménez Quiceno JN, Vanegas Múnera JM, Jiménez Quiceno JN. Colonization and risk of infection by multidrug-resistant bacteria in hemodialysis patients: a topic of concern. Infectio. 2019; 23:205 10.22354/in v23i2.778. [DOI] [Google Scholar]
  • 12.Ewers C, Klotz P, Leidner U, Stamm I, Prenger-Berninghoff E, Göttig S, et al. OXA-23 and IS Aba1 –OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals. Int J Antimicrob Agents. 2017; 49:37–44. 10.1016/j.ijantimicag.2016.09.033 [DOI] [PubMed] [Google Scholar]
  • 13.Hamouda A, Evans BA, Towner KJ, Amyes SGB. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla (OXA-51-like) genes. J Clin Microbiol. 2010; 48:2476–2483. 10.1128/JCM.02431-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li P, Niu W, Li H, Lei H, Liu W, Zhao X, et al. Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A. baumannii in two comprehensive hospitals of Beijing, China. Front Microbiol. 2015; 6:997 10.3389/fmicb.2015.00997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010; 5: e10034 10.1371/journal.pone.0010034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013; 41:11–19. 10.1016/j.ijantimicag.2012.09.008 [DOI] [PubMed] [Google Scholar]
  • 17.Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Internat. J. Antimicrob. Agents. 2013; 41:11–19. 10.1016/j.ijantimicag.2012.09.008 [DOI] [PubMed] [Google Scholar]
  • 18.Li H, Liu F, Zhang Y, Wang X, Zhao C, Chen H, et al. Evolution of carbapenem-resistant Acinetobacter baumannii revealed through whole-genome sequencing and comparative genomic analysis. Antimicrobial agents and chemotherapy. 2015; 59:1168–1176. 10.1128/AAC.04609-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med. 2018; 20:1122–1130. 10.1038/gim.2017.247 [DOI] [PubMed] [Google Scholar]
  • 20.Barbolla RE, Centrón D, Maimone S, Rospide F, Salgueira C, Altclas J, et al. Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting. Am J Infect Control. 2008; 36:444–452. 10.1016/j.ajic.2007.09.010 [DOI] [PubMed] [Google Scholar]
  • 21.Imperi F, Antunes LCS, Blom J, Villa L, Iacono M, Visca P, et al. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life. 2011; 63:1068–1074. 10.1002/iub.531 [DOI] [PubMed] [Google Scholar]
  • 22.Dijkshoorn L, Vianen W Van, Degener JE, Michel MF. Typing of Acinetobacter calcoaceticus strains isolated from hospital patients by cell envelope protein profiles. Epidemiol Infect. 1987; 99:659–667. 10.1017/s0950268800066516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Higgins PG, Wisplinghoff H, Krut O, Seifert H. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect. 2007; 13:1201–210. 10.1111/j.1469-0691.2007.01832.x [DOI] [PubMed] [Google Scholar]
  • 24.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 28th edition. CLSI supplement M100 (ISBN 1-56238-838-X [Print]; ISBN 1-56238-839-8 [Electrinic]). Clinical and Laboratory Standards Institute, 950 West Vally Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2018.
  • 25.Talaga K, Krzyściak P, Bulanda M. Susceptibility to tigecycline of Acinetobacter baumannii strains isolated from intensive care unit patients. Anestezjol Intens Ter 2016; 48: 166–170. 10.5603/AIT.a2016.0021. [DOI] [PubMed] [Google Scholar]
  • 26.Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 2005; 43:4328–4335. 10.1128/JCM.43.9.4328-4335.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Villalón P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, Saez-Nieto JA. Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J. clin. Microbiol. 2011; 49:875–882. 10.1128/JCM.01026-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Di Venanzio G, Moon KH, Weber BS, Lopez J, Ly PM, Potter RF, et al. Multidrug-resistant plasmids repress chromosomally encoded T6SS to enable their dissemination. Nation. Academ. Scien. 2019; 116:1378–1383. 10.1073/pnas.1812557116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 1995; 33:2233 10.1128/JCM.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodríguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 2005; 43:4382–4390. 10.1128/JCM.43.9.4382-4390.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Runnegar N, Sidjabat H, Goh HS, Nimmo GR, Schembri MA, Paterson DL. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 2010; 48:4051–4056. 10.1128/JCM.01208-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Li D, Liu CM, Luo R, Sadakane K, Lam TW. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics. 2015;31:1674–1676. 10.1093/bioinformatics/btv033 [DOI] [PubMed] [Google Scholar]
  • 33.Deplano A, Denis O, Rodriguez-Villalobos H, De Ryck R, Struelens MJ, Hallin M. Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacteria. J Clin Microbiol.2011; 49:3616–3620. 10.1128/JCM.00528-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chan AP, Sutton G, DePew J, Krishnakumar R, Choi Y, Huang X-Z, et al. A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumannii. Genome Biol. 2015; 16:143 10.1186/s13059-015-0701-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hamidian M, Nigro SJ, Hall RM. Problems with the Oxford multilocus sequence typing scheme for Acinetobacter baumannii: do sequence type 92 (ST92) and ST109 exist? J Clin Microbiol. 2017; 55, 2287–2289. 10.1128/JCM.00533-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kenyon JJ, Hall RM. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS One. 2013; 8: e62160 10.1371/journal.pone.0062160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Johnson JK, Robinson GL, Zhao L, Harris AD, Stine OC, Thom KA. Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients. Diagn Microbiol Infect Dis. 2016; 86:345–350. 10.1016/j.diagmicrobio.2016.08.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Saffari F, Monsen T, Karmostaji A, Azimabad FB, Widerström M. Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in southern Iran. J. Med. Microbiol. 2017; 66:1656–1662. 10.1099/jmm.0.000619 [DOI] [PubMed] [Google Scholar]
  • 39.Zowawi HM, Sartor AL, Sidjabat HE, Balkhy HH, Walsh TR, Al Johani SM, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers. Journal of clinical microbiology. 2015;53(3):896–903. 10.1128/JCM.02784-14 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Martina Crivellari

21 Jan 2020

PONE-D-19-35790

Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait

PLOS ONE

Dear Dr Albert,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

ACADEMIC EDITOR:   

  • Dear Authors, I was in doubt for my decision, cause there are many criticism to correct. 

  • There are conflicts between the reviews, actually I think the reviewers are expressing the same concepts; the weak statistical method doesn't permit this manuscript to be accepted as it is. It needs a very accurate revision to be published.  

  • Please shorten introduction, materials and methods. Answer to all the criticism moved by the reviewers in order to make the manuscript ready for publication. 

We would appreciate receiving your revised manuscript by feb 11th. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Martina Crivellari

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

4.  Thank you for stating the following financial disclosure:

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

a) Please provide an amended Funding Statement that declares *all* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  

b) Please state what role the funders took in the study.  If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript describes the molecular typing analysis of Acinetobacter baumannii isolates from a Kuwaitian hospital. It is well written in most parts and could be interesting for the readers of PLOS One. However, due to undeniable weaknesses in methodological procedures and data interpretation, it can not be accepted for publication in its current form.

Major comments:

- the introduction is overlong and should be shortened. This can easily done by a less detailed explanation of the different typing methods.

- the material and methods part is overlong and could easily be shortened by using citations (e.g. description of MLST).

- line 50: nowadays, I would not agree that PFGE is still the gold standard. Since NGS-based typing has become widespread in many countries and as this technique has a at least equivalent or in most cases higher discriminatory power, it should be named as the gold standard. However, no consensus criteria for e.g. cgMLST exist, what is the advantage of PFGE (Tenover criteria).

- line 52: This is not correct. PFGE has a high discriminatory power, even for isolates from different geographic regions. The real problem is, that PFGE results are not comparable from one laboratory to another due to technical variations. But one single laboratory could easily compare isolates from different regions. This has to be changed.

- the authors did not use the Tenover criteria for outbreak investigation by PFGE. I of course know that the Tenover criteria should be used only for isolates within defined time periods, but it would be interesting to know if and how the results change when interpreted with these consensus criteria. This must be done.

- the band patterns shown in figure 1 are of extremely low quality for some isolates that in my oppinion do not allow a reliable data interpretation. e.g. the band pattern isolate Y5a is completely unuseable due to crooked bands. When looking at the bands in detail, for me it does not look like this is another pulsotype than Y5b. Additionally, the DNA amounts seem to be very different for different isolates, which complicates the analysis even more.

The same is the case for isolates R1, R3a, J11, V2 and others... The authors should reperform the PFGE for isolates with poor band patterns.

- table 2: prior to publication, the new MLSTs and CCs must be numbered in coordination with the A. baumannii MLST website.

Minor comments:

- line 44: delete "typing of the isolates to determine their relatedness" as this makes no sense here and seems to be a copy-paste issue

- lines 117/118: "%" is missing for some numbers

- line 121: change it to "cultures...were typed by PFGE."

- line 188: "eBU_R_ST"

Reviewer #2: Al-Hashem et al. present results of a molecular surveillance study on Acinetobacter baumannii on an adult intensive care unit in a tertiary care centre in Kuwait. The study was conducted in a setting where A. baumannii is endemic from March 2016 to June 2017.

The surveillance was based on rectal colonization. From each specimen isolates with different morphotypes were picked and subsequently genotyped. In a pilot study the authors analyzed the association of morphotype and genotype in 12 patients. Analyses were performed with DiversiLab. Based on the pilot study data, the authors concluded that each morphotype represents one genotype.

Rectal colonization with A. baumannii was studied in 493 patients. In 73 out of 493 patients A. baumannii was detected after 72 h of admission. 32 out of theses 73 patients were positive on more than five occasions (serial isolates). Only patients with hospital-acquired (> 72 h after admission) and with serial isolates were included. The authors grouped these 32 patients in six groups based on the “colonization pattern” and picked 13 patients (2-3 from each group, 108 isolates) for further genotypic analysis (PFGE, MLST, eBURST).

The key message is the high diversity of hospital-acquired A. baumannii strains within one patient.

Although the authors did not use whole genome sequencing for genotyping they show with several other methods (PFGE, MLST) that patients are colonized with several different strains at single time points and during hospitalization (overtime).

The article is well-written and easy to understand. Nevertheless, there are several aspects that reduce the scientific impact of this manuscript:

Major revisions

1. The authors do not mention any antibiotic susceptibility data. I recommend adding this data as it is of interest to the reader if patients are colonized with MDR or susceptible strains.

2. The authors compared isolates from one patient and not between the patients in the genotyping analysis. From an infections control perspective it is important to know if there were any transmissions between the patients. Transmissions can be suspected if two patients hospitalized at the same time on the same ward acquired isolates with the same pulsotype/MLST-type (person-to-person- transmission). Environment-to-patient transmissions are more difficult to prove, especially retrospectively, however A. baumannii is known to colonize the environment. For example, PFGE patterns of isolates N3 and Y4 look similar and both patients were hospitalized during the same time period (end of 2016 and beginning of 2017). Please explain, why you decided not to compare isolates of different patients and mention it in the text (limitations?).

3. The discussion is short. Please mention more aspects (epidemiology, are there similar MLST types in the region, consequences for IPC outbreak control and typing etc.).

No limitations are mentioned. One limitation is that the sensitivity and specificity of the microbiological sampling method to detect A. baumannii is not known. Patients may still be colonized by the first strain overtime even if it is not detected.

4. Line 90 “There was no outbreak during the study period.” Please explain. What kind of outbreak do you mean? Outbreaks with any kind of bacteria or A. baumannii? Is there any active surveillance system in place to come to this conclusion? Please, mention in the text.

5. Isolates were considered as identical (100%), related (99-80%) or unrelated (<80%) in the PFGE analysis (Line 137-140). In my opinion, this is a very conservative approach. Even if you run the same isolate on one gel in several lanes you do not necessarily get 100% similarity. I would suggest: 100-97.5% (highly related), 97.5-80% related, <80% unrelated. You also chose a less conservative approach in the DiversLab analysis.

6. Table 1 is part of the results and not part of the methods. Table 1 shows the different groups based on colonization patterns of the patients overtime (identical, related, unrelated isolates). The six groups are complex and difficult to understand.

For example, Patient N is in group 1 “The first isolate disappears and is replaced by an identical or related isolate over time”. However, in my opinion, patient N belongs to group 3 “the first isolate disappears and is replaced by related and unrelated isolates” as there is a relatedness of “FI, -> R-> I -> R-> U”.

A better and more practical subgrouping is proposed in the discussion (line 278-280): “colonization with identical and related isolates (patient Y), colonization with identical, related and unrelated isolates (patients N, R, S, A, AF and K), and colonization with related and unrelated isolates (patients G, J, V, O, B and I).”.

This is the key message of the manuscript. One must consider that patients are colonized with several geno- and phenotypes over time, which is important to know in outbreak situations and to important to trace transmissions. In an outbreak you have to include several isolates from each patient in the genotyping analysis.

7. Whole genome sequencing (line 180-185): Please mention how many isolates and which isolates were analyzed by WGS and why.

8. 493 patients were screened over a period of 16 months. Please mention how many patients were excluded from the study and why (no consent?). I imagine that during the period more patients than 493 were admitted on the ICU.

9. Why did you exclude patients with A. baumannii present on admission (line 218)? Please explain.

Minor revisions

Line 42 – 44: Please rephrase. “This organism has the propensity for acquiring multiple resistance genes with phenotypic expression of multidrug-resistant (MDR) characteristics. MDR strains are now endemic in many hospitals around the world, including hospitals in Kuwait [3,4] typing of the isolates to determine their relatedness.”

Line 47 [6] Consider to mention a study where RAPD was used for A. baumannii.

Line 68. Please mention recent publications where WGS was used for A. baumannii. There are also several recent publications where a cgMLST scheme was established and used for A. baumannii.

Lines 117 – 118: Add %.

Line 125 “v/v sarkosyl, pH 7.5),” Remove the bracket.

Line 178: Please mention the website.

Line 200 – 203: Please shift to methods.

Line 245 “These are shown Table S2”. Please rephrase

Line 244 Please mention in the results section that the new MLST types were uploaded to the MLST server and not in the discussion section (lines 288-289).

Lines 466-474: How many isolates were included in Figure 2 and Figure 3. Please mention in the text.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review_PlosOne_Ghayda_MS1.docx

PLoS One. 2020 Apr 2;15(4):e0230976. doi: 10.1371/journal.pone.0230976.r002

Author response to Decision Letter 0


10 Mar 2020

Response to Reviewers

11/2/2020

Dear Dr. Crivelleri:

Re: PONE-D-19-35790 entitled “Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait”

Thank you for forwarding the reviewers’ comments and your comments. My responses are as below.

ACADEMIC EDITOR:

• Dear Authors, I was in doubt for my decision, because there are many criticisms to correct.

• There are conflicts between the reviews, actually I think the reviewers are expressing the same concepts; the weak statistical method doesn't permit this manuscript to be accepted as it is. It needs a very accurate revision to be published.

• Please shorten introduction, materials and methods. Answer to all the criticism moved by the reviewers in order to make the manuscript ready for publication.

Thank you for your decision to invite a revised manuscript in spite of many comments from the reviewers. We have made extraordinary efforts to answer the comments including shortening the Introduction and Materials & Methods.

Reviewer #1:

The manuscript describes the molecular typing analysis of Acinetobacter baumannii isolates from a Kuwaitian hospital. It is well written in most parts and could be interesting for the readers of PLOS One. However, due to undeniable weaknesses in methodological procedures and data interpretation, it cannot be accepted for publication in its current form.

Major comments:

- the introduction is overlong and should be shortened. This can be easily done by a less detailed explanation of the different typing methods.

Introduction is much shortened now (L39-L74).

- the material and methods part is overlong and could easily be shortened by using citations (e.g. description of MLST).

Materials and Methods section is much shortened now (L76-L157).

- line 50: nowadays, I would not agree that PFGE is still the gold standard. Since NGS-based typing has become widespread in many countries and as this technique has a at least equivalent or in most cases higher discriminatory power, it should be named as the gold standard. However, no consensus criteria for e.g. cgMLST exist, what is the advantage of PFGE (Tenover criteria).

This statement is modified now (L50).

- line 52: This is not correct. PFGE has a high discriminatory power, even for isolates from different geographic regions. The real problem is, that PFGE results are not comparable from one laboratory to another due to technical variations. But one single laboratory could easily compare isolates from different regions. This has to be changed.

This statement is changed now (L50-L52).

- the authors did not use the Tenover criteria for outbreak investigation by PFGE. I of course know that the Tenover criteria should be used only for isolates within defined time periods, but it would be interesting to know if and how the results change when interpreted with these consensus criteria. This must be done.

We did not investigate outbreak in our study. However, we used Tenover criteria, in addition, to interpret the relatedness of isolates (L119-L120; Table 2; L196-L197; L258-L260).

- the band patterns shown in figure 1 are of extremely low quality for some isolates that in my opinion do not allow a reliable data interpretation. e.g. the band pattern isolate Y5a is completely unusable due to crooked bands. When looking at the bands in detail, for me it does not look like this is another pulsotype than Y5b. Additionally, the DNA amounts seem to be very different for different isolates, which complicates the analysis even more.

The same is the case for isolates R1, R3a, J11, V2 and others... The authors should reperform the PFGE for isolates with poor band patterns.

We have repeated PFGE of these isolates several times to improve the quality of gels. What we have presented are the best patterns we have. I am afraid redoing the gels is not going to change the quality of gels or conclusions. For Y5a, even though the middle of the band is a bit drawn up, the pattern is readable. There is a misunderstanding here. We agree that Y5a and Y5b are of the same pulsotype (1c in Table 2). With regard to R1 and R3a, they are clearly different with R3a having an additional band at the top. In Table 2, these isolates are correctly labelled as 1a and 1b.

- table 2: prior to publication, the new MLSTs and CCs must be numbered in coordination with the A. baumannii MLST website.

Unfortunately, in spite of repeated reminders, we have not heard from the curator of the Oxford MLST scheme. Colleagues in Australia and the UK too have complained of a lack of response. Important thing is that we have presented detailed information on the novel STs. If the manuscript is accepted for publication in PLOS ONE, we will communicate the new information to the journal as and when it becomes available.

Minor comments:

- line 44: delete "typing of the isolates to determine their relatedness" as this makes no sense here and seems to be a copy-paste issue

Sorry for the mistake. True, it was a copy-paste issue. The sentence is deleted now (L44).

- lines 117/118: "%" is missing for some numbers

- line 121: change it to "cultures...were typed by PFGE."

Texts containing these lines are deleted while shortening the Introduction, and Materials & Methods.

- line 188: "eBU_R_ST"

The spelling mistake is corrected now (L155).

Reviewer #2: Al-Hashem et al. present results of a molecular surveillance study on Acinetobacter baumannii on an adult intensive care unit in a tertiary care centre in Kuwait. The study was conducted in a setting where A. baumannii is endemic from March 2016 to June 2017.

The surveillance was based on rectal colonization. From each specimen isolates with different morphotypes were picked and subsequently genotyped. In a pilot study the authors analyzed the association of morphotype and genotype in 12 patients. Analyses were performed with DiversiLab. Based on the pilot study data, the authors concluded that each morphotype represents one genotype.

Rectal colonization with A. baumannii was studied in 493 patients. In 73 out of 493 patients A. baumannii was detected after 72 h of admission. 32 out of theses 73 patients were positive on more than five occasions (serial isolates). Only patients with hospital-acquired (> 72 h after admission) and with serial isolates were included. The authors grouped these 32 patients in six groups based on the “colonization pattern” and picked 13 patients (2-3 from each group, 108 isolates) for further genotypic analysis (PFGE, MLST, eBURST).

The key message is the high diversity of hospital-acquired A. baumannii strains within one patient.

Although the authors did not use whole genome sequencing for genotyping they show with several other methods (PFGE, MLST) that patients are colonized with several different strains at single time points and during hospitalization (overtime).

The article is well-written and easy to understand. Nevertheless, there are several aspects that reduce the scientific impact of this manuscript:

Major revisions

1. The authors do not mention any antibiotic susceptibility data. I recommend adding this data as it is of interest to the reader if patients are colonized with MDR or susceptible strains.

Susceptibility data are now added (L96-L101; L185-L188).

2. The authors compared isolates from one patient and not between the patients in the genotyping analysis. From an infections control perspective, it is important to know if there were any transmissions between the patients. Transmissions can be suspected if two patients hospitalized at the same time on the same ward acquired isolates with the same pulsotype/MLST-type (person-to-person- transmission). Environment-to-patient transmissions are more difficult to prove, especially retrospectively, however A. baumannii is known to colonize the environment. For example, PFGE patterns of isolates N3 and Y4 look similar and both patients were hospitalized during the same time period (end of 2016 and beginning of 2017). Please explain, why you decided not to compare isolates of different patients and mention it in the text (limitations?).

This is addressed (L284-L288).

3. The discussion is short. Please mention more aspects (epidemiology, are there similar MLST types in the region, consequences for IPC outbreak control and typing etc.).

This is now done (L271-L280).

No limitations are mentioned. One limitation is that the sensitivity and specificity of the microbiological sampling method to detect A. baumannii is not known. Patients may still be colonized by the first strain overtime even if it is not detected.

Limitations are mentioned now (L281-L288).

4. Line 90 “There was no outbreak during the study period.” Please explain. What kind of outbreak do you mean? Outbreaks with any kind of bacteria or A. baumannii? Is there any active surveillance system in place to come to this conclusion? Please, mention in the text.

Sorry, this statement was included inadvertently. There is no active surveillance, but if there is a suspicion of outbreak due to any bacteria, then, investigation is carried out.That way, there was no separate investigation during our study period.

5. Isolates were considered as identical (100%), related (99-80%) or unrelated (<80%) in the PFGE analysis (Line 137-140). In my opinion, this is a very conservative approach. Even if you run the same isolate on one gel in several lanes you do not necessarily get 100% similarity. I would suggest: 100-97.5% (highly related), 97.5-80% related, <80% unrelated. You also chose a less conservative approach in the DiversLab analysis.

Because of the nature of the question asked in the study, it was necessary to adopt conservative criteria for PFGE analysis. It was a different question with regard to DiversiLab analysis. Therefore, I am afraid, the adopted approaches are justified.

6. Table 1 is part of the results and not part of the methods. Table 1 shows the different groups based on colonization patterns of the patients overtime (identical, related, unrelated isolates). The six groups are complex and difficult to understand.

For example, Patient N is in group 1 “The first isolate disappears and is replaced by an identical or related isolate over time”. However, in my opinion, patient N belongs to group 3 “the first isolate disappears and is replaced by related and unrelated isolates” as there is a relatedness of “FI, -> R-> I -> R-> U”.

A better and more practical subgrouping is proposed in the discussion (line 278-280): “colonization with identical and related isolates (patient Y), colonization with identical, related and unrelated isolates (patients N, R, S, A, AF and K), and colonization with related and unrelated isolates (patients G, J, V, O, B and I).”.

This is the key message of the manuscript. One must consider that patients are colonized with several geno- and phenotypes over time, which is important to know in outbreak situations and to important to trace transmissions. In an outbreak you have to include several isolates from each patient in the genotyping analysis.

We agree with this excellent suggestion and changed the grouping of patients (Table 1in Results; L199-L201).

7. Whole genome sequencing (line 180-185): Please mention how many isolates and which isolates were analyzed by WGS and why.

This is now mentioned (L149-L151).

8. 493 patients were screened over a period of 16 months. Please mention how many patients were excluded from the study and why (no consent?). I imagine that during the period more patients than 493 were admitted on the ICU.

We included all patients.

9. Why did you exclude patients with A. baumannii present on admission (line 218)? Please explain.

This is now explained (L180-L182).

Minor revisions

Line 42 – 44: Please rephrase. “This organism has the propensity for acquiring multiple resistance genes with phenotypic expression of multidrug-resistant (MDR) characteristics. MDR strains are now endemic in many hospitals around the world, including hospitals in Kuwait [3,4] typing of the isolates to determine their relatedness.”

Sorry for the mistake. The last line was inadvertently introduced by mistake while cutting and pasting. It is now deleted (L42).

Line 47 [6] Consider to mention a study where RAPD was used for A. baumannii.

Reference 6 is now for A. baumannii.

Line 68. Please mention recent publications where WGS was used for A. baumannii. There are also several recent publications where a cgMLST scheme was established and used for A. baumannii.

Now reference 18 is appropriate (L58).

Lines 117 – 118: Add %.

Line 125 “v/v sarkosyl, pH 7.5),” Remove the bracket.

These are deleted while shortening the Methods section.

Line 178: Please mention the website.

Now mentioned (L141).

Line 200 – 203: Please shift to methods.

Done (L104-L106)).

Line 245 “These are shown Table S2”. Please rephrase

Done (L166, now Table S1).

Line 244 Please mention in the results section that the new MLST types were uploaded to the MLST server and not in the discussion section (lines 288-289).

Done (L222-L223).

Lines 466-474: How many isolates were included in Figure 2 and Figure 3. Please mention in the text.

The numbers are not relevant. The figures are constructed based on sequence types.

I hope that I have answered all comments satisfactorily.

With kind regards

Yours sincerely

Professor M. John Albert

Department of Microbiology

Faculty of Medicine

Kuwait University

Kuwait

Attachment

Submitted filename: Ghayda-PLOSONE-ResponseToReviewerComments.docx

Decision Letter 1

Martina Crivellari

13 Mar 2020

Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait

PONE-D-19-35790R1

Dear Dr. Albert,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Martina Crivellari

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Martina Crivellari

20 Mar 2020

PONE-D-19-35790R1

Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait

Dear Dr. Albert:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Martina Crivellari

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. The relationship of colonies by DiversiLab dendrograms among similar and different morphotypes.

    (DOCX)

    S2 Table. Antimicrobial susceptibilities of 108 serial rectal A. baumannii isolates from 13 patients.

    (DOCX)

    S3 Table. Combination of gene alleles for novel MLSTs.

    (DOCX)

    S1 Fig. The relationship of colonies of similar and different colony morphotypes by DiversiLab dendrogram.

    Patients 1, 5 and 7 each had similar colony morphotypes. Three colonies each from these patients were genetically identical by DiversiLab. Patients 3, 6 and 8 had 3, 4 and 6 colony morphotypes, respectively. DiversiLab analysis of these colonies showed different genetic types.

    (TIF)

    S2 Fig. Novel cpn60 allele and genome sequence based MLST type for the Oxford scheme from isolate O3 (designated as NEW3) (fasta file).

    (TIF)

    S3 Fig. gpi sequence of A. baumannii isolate K5 (designated as NEW4) showing lack of binding of forward primer.

    (TIF)

    Attachment

    Submitted filename: Review_PlosOne_Ghayda_MS1.docx

    Attachment

    Submitted filename: Ghayda-PLOSONE-ResponseToReviewerComments.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES